Gasotransmitters, poisons, and antimicrobials: it's a gas, gas, gas! by Tinajero-Trejo, M. et al.
Gasotransmitters, poisons, and antimicrobials: it’s a gas, gas, gas!
Mariana Tinajero-Trejo*, Helen E. Jesse* and Robert K. Poole*
Address: Department of Molecular Biology and Biotechnology, The University of Sheffield, Firth Court, Western Bank, Sheffield S10 2TN, UK
*Corresponding author: Mariana Tinajero-Trejo (mbp09mt@sheffield.ac.uk); Helen E. Jesse (mbp09hej@sheffield.ac.uk); Robert K. Poole
(r.poole@sheffield.ac.uk)
F1000Prime Reports 2013, 5:28 (doi:10.12703/P5-28)
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License
(http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited. You may not use this work for commercial purposes.
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/28
Abstract
We review recent examples of the burgeoning literature on three gases that have major impacts in
biology and microbiology. NO, CO and H2S are now co-classified as endogenous gasotransmitters
with profound effects on mammalian physiology and, potentially, major implications in therapeutic
applications. All are well known to be toxic yet, at tiny concentrations in human and cell biology, play
key signalling and regulatory functions. All may also be endogenously generated in microbes. NO and
H2S share the property of being biochemically detoxified, yet are beneficial in resisting the
bactericidal properties of antibiotics. The mechanism underlying this protection is currently under
debate. CO, in contrast, is not readily removed; mounting evidence shows that CO, and especially
organic donor compounds that release the gas in biological environments, are themselves effective,
novel antimicrobial agents.
Introduction and chronology
Gases play critical roles in life on earth. In microbiology,
the best-known gases are nutrients or metabolites: dioxy-
gen, carbon dioxide, dinitrogen, dihydrogen, methane
and others [1]. This article highlights the extraordinary
advances that have beenmade in the biology of three other
gases – nitric oxide (nitrogen monoxide, NO), carbon
monoxide (CO) and hydrogen sulfide (H2S).
Great strides forward in understanding how andwhy these
gases are important in mammalian physiology have kick-
started a new area of “gasotransmitters”, i.e. small gaseous
molecules that play key roles in biology, illustrated by a
large number of reviews published in the last few years
(see below). All these gases penetrate membranes, are
poisons in excess, are endogenously generated and have
important biological targets, especially metalloproteins
[2-4]. The discovery in the 1980s that NO produced by
mammalian NO synthases is important in the cardiovas-
cular, immune and nervous systems [5-8] was the first
impetus to this new area of biology [9]. A decade later,
CO emerged as a neurotransmitter and regulator of the
cardiovascular and immune systems [10-13]. Most
recently, H2S has emerged as a third gasotransmitter,
with key roles in the nervous and cardiovascular systems
and regulation of cellular and whole body metabolism
(reviewed in [14,15]). The literature on the biology of
these three gases is now so vast that these and other
reviews must act as a surrogate for the relevant papers:
[16-20]. In the microbial world too, all three gases have
important long-recognised roles: NO is an intermediate in
denitrification [21] and is detoxified bypathogens [22,23],
CO is an unusual carbon and energy source [24], and H2S
is well known to all microbiologists as a product of anoxic
sulfate respiration [25]. Each gas is suggested to have
valuable therapeutic applications [26,27].
Here, we present recent advances in the field that cement
the view that each of these gases is not only toxic but also
plays essential roles in metabolism. Toxicity has been
most clearly harnessed by the innate immune response in
the use of NO as a chemical weapon against pathogens,
but may also find future applications via the therapeutic
delivery of CO to pathogens. We look at the surprising
evidence that NO and H2S protect bacteria from the lethal
effects of antibiotics. As a corollary, we report on two new
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papers that challenge the premise that these gases act as
antioxidants.
Lessons from mammalian physiology
The era of gas biology started with the recognition that
NO was the elusive “endothelium-derived relaxing factor”
(EDRF), a messenger (or gasotransmitter in current
nomenclature) produced by endothelial cells that leads
to vascularmuscle relaxation. In 1998, this work led to the
award of the Nobel Prize for Physiology or Medicine to
Murad [28], Furchgott [8] and Ignarro [7]. A fourth major
proponent of this idea, Salvador Moncada, was not so
honoured. The story of these discoveries and the ensuing
escalation of research on NO are now well known. NO
is generated in man by a family of NO synthases (NOS,
i.e. inducible NO synthase, endothelial NO synthase etc.)
from arginine and has many critical roles in the cardi-
ovascular, immune and central nervous systems. NO is the
most chemically reactive of the gasotransmitters consid-
ered here and is a toxic radical: it is employed in the
immune response of macrophages, constituting a key
component of the arsenal of damaging species directed at
engulfed pathogens [23]. Although Sjostrand provided
experimental evidence for the endogenous production
of CO in man in 1950, it was only in 1991 that Marks
and others [10] hypothesised that CO might be another
gasotransmitter, produced by haem oxygenases. Indeed,
manyof its physiological effects are similar to those ofNO:
roles in neurotransmission and platelet aggregation and
anti-apoptotic activity are well documented. Nevertheless,
CO is more notorious as the “silent killer”, while H2S is
more toxic to humans than HCN [3]. Less is known about
H2S, but it is synthesised endogenously and opens
vascular smooth muscle channels [29].
All these compounds are gases at atmospheric pressure,
all are more (H2S) or less soluble in water and, being
small and uncharged, move freely through membranes.
No dedicated transporters are expected for the gases,
but the nitrosating agent S-nitrosoglutathione (which
is widely used experimentally as a source of “reactive
nitrogen species”) is modified on transport through the
periplasm and cytoplasmic membrane (Fig. 1). The jury is
out on whether CO-releasing molecules must be trans-
ported inwards or can be expelled from cells. The sulfide
anion that accumulates in the bacterial cytoplasm can be
moved out by a specific transporter. Some of the salient
physicochemical features of these gases and a comparison
with oxygen are summarised in Table 1 and Fig. 1 shows
their origins and effects.
Nitric oxide – the old hand
Nitric oxide and reactive nitrogen species now occupy
central positions in contemporary medicine, physiology,
biochemistry and microbiology. All these species are
generated in biological systems from initial formation of
NO (from nitrite, NO synthases, or other sources). The
major targets ofNOand reactive nitrogen species aremetal
centres (Table 1) and thiols, so that numerous critical
biomolecules are at risk. Not surprisingly, microbes have
evolved mechanisms for resisting or reversing such
damage and many of these are critical for pathogenicity;
such measures include the activities of hemoglobins that
enzymically detoxify NO (to nitrate) [30], respiratory and
NADH-linked NO reductases [31] and repair mechanisms
(for example, those that reverse S-nitrosothiol formation)
[32]. Microbial resistance to these stresses is generally
inducible via the action of NO-sensing transcriptional
regulators (such as Fnr, NorR, NsrR, NssR) [33,34]. How-
ever, a phenomenal growth in the literature on NO has
often not gone hand in hand with an understanding of
the intricacies and complexities of nitrogen chemistry.
The distinctiveness of NO and its chemical cousins,
nitrosonium (NO+), nitroxyl (NO−, HNO), peroxynitrite
(ONOO−), nitrite (NO2
−) and nitrogen dioxide (NO2) has
been critically reviewed recently [22]. Unfortunately, some
authors write “NO”when it is actually meant “in a generic
sense”, thus confusing the biological literature. It should
not be necessary to write “NO radical” to eliminate the
possibility that one is actuallymeaningNO+ or someother
congener. There is only one NO.
There is a growing literature on signalling functions for
NO in microbes. An interesting example is the influence
of NO on biofilm formation. Recently it has been reported
that NO derived from periplasmic reductase positively
influences biofilm formation in Azospirillum brasilensae
[35]. Conversely, NO donors aid in dispersing biofilms of
Pseudomonas aeruginosa [36]. Recently, an NO sensor has
been identified in Vibrio fischeri: H-NOX appears to be part
of a signal transduction pathway to detect host-produced
NO and influence iron utilisation genes [37,38].
NO is most efficiently detoxified in bacteria by the activity
of haemoglobins that catalyse the conversion of NO and
dioxygen to nitrate anion (Fig. 1). The best characterised
such proteins are flavohaemoglobins but, even now,
15 years after this reaction was first proposed for the
Escherichia coli protein [39], and 17 years since the finding
that flavohaemoglobin gene expression was dramatically
up-regulated by NO [40], there is still controversy about
the reaction mechanism. Two recent reviews [41,42]
assume the reaction to proceed via an NO dioxygenation
mechanism in which oxygen binds to the ferrous haem,
followed by NO. However, since 2001, Stamler’s group
in situ ,
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have favoured an alternative denitrosylase mechanism in
which the protein binds NO during turnover and
rapidly catalyses nitrate formation across a wide range of
debated in letters [44,45] that promptly followed the
flavohaemoglobins do catalyse the rapid detoxification of
NO to nitrate and play a critical role in the response of
pathogenicmicroorganisms to the innate immune system.
An interesting computational approach to the complexity
of NO biochemical networks has just been published [46]
and concluded that Hmp is the dominant NO-consuming
pathway at oxygen concentrations down to about 35 µM
but, interestingly, loses effectiveness as NO delivery rates
increase.
Figure 1. Simplified schematic diagram of the origins of NO, CO and H2S in bacteria and their major physiological effects
(a) NO accesses the cell interior via free passage through the membrane. The commonly used nitrosating agent, S-nitrosoglutathione (GSNO), a tripeptide, is
hydrolysed in the periplasm and the nitrosated dipeptide transported inwards via a dipeptide permease (DPP) [32]. Intracellular NO is also generated by
bacterial NO synthases (bNOS) [59] from arginine or anaerobically by nitrite reduction (not shown). NO or GSNO exhibit complex biological chemistry
leading to the formation of various N oxides, especially S-nitrosothiols (SNOs) [22,32]. The best understood route for NO detoxification is a dioxygenase
or denitrosylase reaction with oxygen catalysed by the flavohaemoglobin Hmp [22].
(b) CO accesses the cell interior via free passage through the membrane. CO-releasing molecules (CO-RMs) may or may not require transport systems.
Release of CO from CO-RMs yields an “inactive” form (iCO-RM) either inside or outside the cell, the biology of which needs careful consideration [81]
The fate of CO-RM or iCO-RM is unknown but efflux systems might operate. CO is also generated endogenously in certain bacteria by haem
oxygenases (HO) from the breakdown of haem (red diamonds).
(c) H2S accesses the cell interior via free passage through the membrane but the hydrosulfide anion, which is prominent intracellularly by virtue of the
pH gradient, may be exported by a specific transporter (yellow) [91]. Three endogenous mechanisms for H2S generation from Hcy and Cys have
been identified [99].
(d) Global consequences of the three gases include activation of gas-specific transcription factors (TFs), inhibition of respiratory oxygen reduction by binding
to the haem(s) of terminal oxidases, and modulation of bacterial ion transport [77]. Q, quinones involved in respiration.
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oxygen concentrations . These alternative views are
Forrester review [42]; however, it is not disputed that
[43]
Even though (almost) all haemoglobins (flavohaemog-
lobins, single-domain and truncated globins) seem to
possess NO-consuming activity, this physiological func-
tion in vivo has been demonstrated for only a few globins.
Indeed, of the very large number of globin sequences
identified in prokaryotic genomes (c. 1161 globin-
containing genomes), only a handful has been subjected
to rigorous genetic and physiological characterisation and
the vast majority of the evidence pertains to flavohaemo-
globins [47]. The most notable exception is the single-
domain globin of Campylobacter jejuni, a myoglobin-like
protein that is expressed in bacteria on challenge with NO,
and mutation of which elicits an NO-sensitive phenotype
[47,48]. The true function of most microbial globins is
unknown [47].
Although many globin crystal structures from all classes
are available (at least 15 bacterial and archaeal globins),
understanding globin function(s) has not been greatly
facilitated by these structures or by the numerous elegant
kinetic experiments on ligand binding to the purified
proteins. For example, the structure of the second
(truncated) haemoglobin from C. jejuni has been solved
[49-51] and its oxygen affinity is remarkably high [52],
but we still do not understand its role in vivo.
The expression of globins in a convenient heterologous
host is often exploited to test functional properties when
genetic manipulation of the native host is difficult. An
especially useful model is the flavohaemoglobin-lacking
E. coli (hmpmutant), which is hypersensitive to NO.When
complementation of the phenotype is observed, it is
generally interpreted to demonstrate detoxification prop-
erties for the heterologously expressed globin (for a recent
example, see [53]). However, the discovery of a function
in a heterologous organism does not necessarily tell us
that the protein will have the same function in the native
host, especially when the bacteria are phylogenetically
distant. For example, the requirement for interaction with
a cognate reductase by single-domain or truncated globins
(as in [53]) and/or for oxygen for the NO→NO3
− reaction
may be accomplished in E. coli but not in the native host
(reviewed in [47]).
Although generally harmful, NO may have beneficial
effects, as in the case of the squid-Vibrio light-organ
symbiosis, where NO serves as a signal, antioxidant and
specificity determinant [54-56]. A recent high-profile case
concerns the NO generated endogenously by certain
bacteria from arginine by the activity of bacterial NO
synthase (Figs. 1,2). Two papers reported that this NO
protects bacteria against oxidative stress [57,58]. Later,
many antibacterial agents were shown to suppress growth
of a nos mutant lacking bacterial NO synthase [59]. The
authors suggest that NO-mediated antibiotic resistance is
explained in two ways: first, by chemical modification of
the toxic compounds (for example, the nitrosation byNO+
of aromatic amino groups on acriflavine) and, second, by
NO-protecting bacterial cells against the oxidative stress
that antibiotics like quinolones generate (Fig. 2). How-
ever, two very recent papers in Science question the
premise that killing by bactericidal antibiotics depends
on reactive oxygen species (see below).
Carbon monoxide – the new NO?
CO is among the most abundant air pollutants in
developed countries and its dangers are compounded by
difficulties in detecting it. Tragic cases of CO fatalities are
frequent in the media, including one recently involving
many street children in China (http://www.bbc.co.uk/
news/world-asia-china-20389004). Nevertheless, the
ability of animals, plants and pathogenic microbes to
make CO via haem oxygenase enzymes is widespread
and the CO generated has potent beneficial biological
consequences [60]. CO is now identified as a “gaso-
transmitter” with wide-ranging effects on vasodilation
and inflammation [10-12]. The emerging view is that
CO and CO-releasing molecules have biological effects
Table 1. Physicochemical properties of oxygen and three gasotransmitters
Oxygen, O2 Carbon monoxide, CO Nitric oxide, NO Hydrogen sulfide, H2S*
Molar mass, g/mol 32 28 30 34
Solubility in water, 20 oC 0.0043 0.0028 0.0062 0.40
Molecular size (pm) 121 113 115 134
Importance of redox
metabolism in biology
+++ + ++ (radical) ++
Haem ligand? yes yes yes yes
Metal binding +++ +++ +++ +++
Major mechanisms of
endogenous generation
Catalase, photosynthesis Haem oxygenases NO synthases, nitrate/nitrite
respiration, from SNOs
(minor)
CBS, CSE, MST, sulfate
reduction
Important roles in microbes Major biological oxidant and
co-substrate
Carbon and energy source Intermediate in denitrification,
antibiotic resistance
Metabolic intermediate,
antibiotic resistance
* pKa is 6.8, so HS
− is dominant species in biology
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far-removed from the classical view that CO is a toxic gas,
useful to haem biochemists, but merely a by-product of
haem oxygenase-catalysed haem degradation.
In certain bacteria, CO is an oxidisable substrate andmust
be sensed. In Rhodospirillum rubrum and Carboxydothermus
hydrogenoformus [61], the coo operon encodes a CO
dehydrogenase, which allows the anaerobic metabolism
of CO. The expression of this operon is regulated by the
CO sensor CooA [62], a member of the CRP/FNR family.
In response to a reducing cellular environment, CO
binds to ferrous haem of CooA, causing a conformational
change that permits DNA binding and therefore transcrip-
tion of the coo operon [63,64]. Recently, an ingenious
use of CooA has been described in which the natural
sensitivity of CooA to CO has been exploited in a sensitive
fluorescent protein reporter for CO imaging in living cells
[65]. However, homologues of this canonical CO oxida-
tion system, including CooA, CO dehydrogenase, and a
CO-dependent Coo hydrogenase, are also present in the
sulfate-reducing bacterium Desulfovibrio vulgaris, although
it grows only poorly on CO. Recent global transcriptional
analyses suggests that CooA and CO dehydrogenase are
used during normal metabolism of this bacterium [66].
Another haem-containing CO sensor, RcoM from Bur-
kholderia xenovorans, which is also able to bind NO,
regulates the expression of genes in response to the redox
state of the cell [67,68].
CO also has useful antibacterial features. It enhances
phagocytosis of E. coli [69] by macrophages and shows
promising effects on bacteraemia in sepsis [12,70].
Because of the difficulties of studying CO in the laboratory
and using it therapeutically (see, however, [71]), CO-
releasing molecules, mostly metal carbonyl compounds,
developed decades ago by chemists, have more recently
been used in biological studies [72]. These release CO in
biological milieu with defined kinetics and stoichiometry,
promoted by reaction with other species [73] or enzymic
or photochemical activation [74]. CORM-3 (Ru(CO)3Cl
(glycinate)) is a water-soluble CO-releasing molecule that
has numerous beneficial effects in mammalian systems
and is an effective antibacterial agent [75]. CORM-3
decreased bacterial counts in the spleen and increased
survival of mice following experimental bacteraemia [76];
injection into mice increased phagocytosis of Enterococcus
faecalis and rescued haem oxygenase-deficient mice from
sepsis-induced lethality [70]. Thus, therapies involving
haem oxygenases, CO or CO-releasing molecules have
great potential for treating infections [12], but the
microbiological literature on these compounds is very
limited and only a handful of the hundreds of CO-
releasingmoleculesmade over the past few years have been
tested againstmicrobes. At the time of writing, for example,
no papers on the effects onmicrobes of any photo-CORM,
which releases CO on demand after photolysis, have
appeared. Our rudimentary knowledge of the modes of
actions of CO and CO-releasing molecules, and the
difficulty of drawing conclusions from so few CO-releasing
molecules limits progress.
In many cases, the antimicrobial effects of CO-releasing
molecules are clearly caused by the released CO, as control
molecules that do not release CO do not induce these
effects [75,77]. However, there is mounting evidence that
CO-releasing molecules are much more powerful anti-
bacterial agents than CO [75,78] and elicit biological
effects beyond those of CO gas. For example, CO-releasing
molecules exhibit antimicrobial effects even under highly
aerobic conditions where CO gas is ineffective (because
the gas is a competitive inhibitor with oxygen) [75].
Furthermore, a recent study of the effects of CORM-3 on
the respiration of a range of bacteria found that this CO-
RM elicited in E. coli transient stimulation of respiration,
prior to respiratory inhibition; these effects were not
mimicked by CO gas [77]. Uncoupling of respiration by
promotion of proton flux, as proposed in mitochondria
[79,80], was ruled out. In E. coli, the working hypothesis is
that CO-releasing molecules cause the opening of other
ion channels (K+,Na+), which transiently collapses the
Figure 2. Proposed interactions between NO, CO and H2S
with antibiotics and oxidative stress in bacteria
All three gases are potent inhibitors of terminal oxidase activity in bacteria,
leading to the accumulation of ROS (reactive oxygen species), initially
superoxide anion (O2
−) and hydrogen peroxide (H2O2). ROS are detoxified
by superoxide dismutases (SOD) and catalases. ROS may also be generated
by chemically unrelated antibiotics [102], although this is now disputed
[104,105]. Antibiotics may also increase NO formation from bNOS [59]
while H2S induces activity of SOD and catalase.
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protonmotive force and disturbs ion transport. The reason
that CO-releasing molecules potentiate the effects of CO
may be that they deliver CO directly into bacterial cells,
thereby allowing a high concentration of this gas to
accumulate at the sites of action [75] – the “Trojan Horse”
mechanism [77].
As described above, CO is a classical inhibitor of res-
piration in both eukaryotes and prokaryotes, and CO
from CO-releasing molecules shares this property. CO is
delivered from CO-releasing molecules directly to the
haems of cytochromes bd and bo’ of the aerobic respiratory
chain of E. coli and transcriptomic profiling has shown that
exposure of E. coli to CORM-3 results in down-regulation
of the cyo genes encoding cytochrome bo’ and slight up-
regulation of the cydAB genes encoding cytochrome bd-I
[75], suggesting a role for cytochrome bd-I in resisting
CORM-3. Subsequent time-resolved analysis revealed that
the transcription of appBC, which encodes cytochrome
bd-II is not affected in response to CORM-3 [81]. In
support, a strain expressing cytochrome bd-I as the sole
oxidase is less susceptible to both respiratory and growth
inhibition by this compound [82], consistent with the
established role of this oxidase in resisting a variety of
environmental stresses including NO [83]. In the case of
NO, it has been proposed that cytochrome bd resists
inhibition because of an exceptionally high off rate (koff
0.163 s−1 for cytochrome bd, compared to 0.03 s−1 for
cytochrome bo’ [83]), although it is difficult to draw such
conclusions for CO due to discrepancies in the literature
as to the off rate of this gas from cytochrome bd-I (see
references in [82]).
CO is implicated inmany recent studies as an antioxidant,
for example in ischemia-reperfusion injury in vitro [84].
On the other hand, because CO is a potent inhibitor of
respiration, it may increase generation of reactive oxygen
species in mitochondria [85,86] or bacteria [87] (Fig. 2).
One recent study [88] suggests that CORM-2 promotes the
formation of reactive radical species, even in the absence
of cells, and that such species are largely responsible for
CORM-mediated bacterial killing. This assertion appears
to be supported by the oft reported, but poorly under-
stood, observation that N-acetylcysteine protects against
CORM-2 and CORM-3 toxicity (e.g. [76,89]). Other data,
however, contradict this view [81]; some antioxidants do
not share this property and N-acetylcysteine is effective
at inhibiting CO-RM uptake by E. coli, presenting us with
a new testable hypothesis for the protective effects of
N-acetylcysteine [82]. The field is in a state of flux and
further insights are anticipated but, unlike the case for
NO (above) and H2S (below), there appears to be no clear
evidence yet that CO or CO-releasing molecules either
protect against antibiotics or potentiate their activities.
Hydrogen sulfide – an (un)welcome gate crasher?
Hydrogen sulfide is a toxic, freely permeable, malodo-
rous gas. It is very soluble in water (Table 1) and the
equilibrium between its three states (H2S, HS
− and S2−) is
pH-dependent. Here, we write “H2S” or “sulfide” (HS
−)
while recognising the importance of pH in controlling
speciation [90]. At 37 oC the pKa is 6.76; since the pH of
the human large intestine is in the range 5.5-7.0, H2S and
HS− are the predominant sulfide species, and the hydro-
sulfide anion (HS−) will be the dominant species inside
gut bacteria [91]. An exporter for this anion has been
identified in Clostridium difficile [91]. Recently, H2S has
been recognized as an important gasotransmitter in
higher organisms (reviewed by [15,92,93]). This gas is
abundant in the anaerobic lumen of the gut (1-2mM total
sulfide) with ~60 µM being present in a free, unbound
form where it is generated by the reduction of sulfate and
the decomposition of sulfur-containing organic com-
pounds, such as cysteine, by resident microflora. Sulfate-
reducing bacteria generate H2S by the reduction
of various sulfur compounds, e.g. SO4
2− or S0 under
anaerobic conditions, often using H2 or simple organic
molecules as an electron donor. H2S and SO4
2− are also
generated by bacterial disproportionation of thiosulfate.
Furthermore, human faecal slurries ferment cysteine, (via
the action of cysteine desulfurases, which yield H2S,
ammonia and pyruvate) and other organic sulfur
compounds [94]. Dietary polysulfides from “healthy”
sources (garlic, onions etc.) further increase formation of
H2S. Thus, H2S is abundant in the anaerobic environment
of the mammalian lower intestine and consequently the
gut epithelium is exposed to this potent signalling
molecule and toxin.
Exogenous H2S modulates the behaviour of intestinal
epithelium cells [95]; however, the effects of exposure
to exogenousH2S are considered less significant than those
elicited by endogenous H2S production by the enzymes
cystathionine-b-synthase and cystathionine-g-lyase
[92,96]. Endogenous H2S levels are uncertain because of
extraction and binding issues, but tissue homogenates
and other material produce 1-10 µM of free H2S in the
presence of cysteine and low O2. These significant con-
centrations control the relaxation of blood vessels, inhibit
inflammation, and modulate neuronal activity [92]. The
precise molecular mechanisms by which H2S elicits
these positive effects are not well established. However,
the thiol groupsof protein cysteine residues aremodifiedby
H2S yielding hydropersulfide moieties (S-sulfhydration),
which can result in altered activity. For example,
glyceraldehyde-3-phosphatedehydrogenase (GAPDH)activ-
ity is enhanced seven-fold by S-sulfhydration of Cys-150
[97]. Thus,S-sulfhydration is an important post-translational
modification in higher organisms, with implications for
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protein function and transduction of the H2S signal into
altered behaviour.
As well as acting as an important signalling molecule,
H2S damages cell components and mediates its toxic
effects, at least in part, by inhibiting respiration, reacting
with other metals and by reducing protein disulfide
bonds. Terminal respiratory oxidases have been known
to be inhibited by H2S for many decades [2]. Although
the significance of H2S signalling in higher organisms is
now established, essentially nothing is known about the
effect of H2S on gut bacteria that are exposed to
fluctuating concentrations of exogenous H2S in their
preferred niche and/or that generate endogenous H2S
[98]. Themajor source of endogenous H2S production by
E. coli, identified by Shatalin et al. [99], was the combined
action of the L-cysteine transaminase (AspC) and the
3-mercaptopyruvate sulfurtransferase SseA (MST). How-
ever, there are several other potential H2S-generating
enzymes in E. coli, including CysJI, MetC, TnaA and
H2S-consuming enzymes, e.g. CysEK and CysM. In other
bacteria like Bacillus anthracis, Staphylococcus aureus and
P. aeruginosa, themainmechanisms are via cystathionine-
b-synthase/cystathionine-g-lyase [99]. We know much
less about potential resistance mechanisms for H2S in
bacteria, but plant pathogenic bacteria use the bigR
operon for H2S detoxification via the action of a sulfur
dioxygenase (Blh) and a sulfite exporter [100].
Emerging information on the biological roles of H2S is
likely to have significant impact in the foreseeable future,
following the demonstration [99] that H2S protects
bacteria from a diversity of antibiotics by mitigating the
effects of oxidative stress. Note, however, that this contrasts
with a previous report that H2S potentiates hydrogen
peroxide-induced killing of E. coli [101]. The suggestion
that H2S can act as “a universal defence against antibiotics
in bacteria” [99] is predicated on the assumption, first, that
H2S is an antioxidant and, second, that numerous
antibiotics exert their bactericidal activities by mitigating
oxidative stress. Let us now examine the second of these.
Gas interactions with microbes, antibiotics and
other antimicrobial agents - do we really
know how antibiotics work?
The papers cited above from Shatalin [58,99], Gusarov
[57,59] and others suggest that, separately, NO and H2S
production may constitute a natural bacterial defence
method against antimicrobial compounds. The specific
proposal is that these gases (but not CO, yet) partially
neutralise the effectiveness of antibiotics by suppressing
the oxidative stress that antibiotics induce. This model
of antibiotic action [102,103] appears to be a unified
explanation of the effectiveness of numerous bactericidal
compounds that all induce the formation of reactive
oxygen species by inhibiting the electron transport chain.
However, this model fails to explain many aspects of
antibiotic action, such as the effectiveness of bactericidal
antibiotics against lacks
any electron transport chain. Recently, Keren et al. [104]
have produced persuasive evidence that a cell’s probabi-
lity of survival in the presence of an antibiotic does
not correlate with the level of reactive oxygen species.
Furthermore, thiourea, a reagent that quenches reactive
oxygen species, is equally effective at protecting cells from
antibiotics under anaerobic conditions, when reactive
oxygen species cannot be formed. Likewise, Liu and Imlay
[105] show that antibiotic treatment does not promote
hydrogen peroxide generation or elevate intracellular
free iron, a precursor to reactive oxygen species-induced
damage via Fenton chemistry.
Perhaps curiously, neither of themost recentSciencepapers
[104,105] mention the implications of their findings
for the protection by NO and H2S against bactericidal
antibiotics. We are therefore left with puzzles: what is
the mechanism of gas-mediated antibiotic resistance, does
CO share this remarkable property and can the clinical
effectiveness of antibiotics be modulated by endogenous
microbial gas production? Only time will tell.
Questions, controversies, and conflicts
There is no doubt that NO, CO and H2S play key roles
in bacterial life, survival strategies and metabolism,
undreamt of a few decades ago. Despite the rapid progress
on all three gases in the mammalian field, only NO has
achieved a degree of prominence in microbiology as a
gasotransmitter or signalling molecule. CO and H2S
deserve more attention and the possible link between
the latter and antibiotic tolerance should kick-start such
activity. In the case ofCO, all the evidence points at present
to its potential as an antimicrobial agent, rather than a
protective molecule for bacteria. In fact, we are unaware
that antibiotic tolerance elicited by CO has ever been
reported. CO and other products of haem degradation are
considered as antioxidants in mammalian systems, but it
remains to be seen whether CO can exert such a role in
bacteria, or even whether the concept that antibiotics kill
bacteria by stimulating reactive oxygen species formation
withstands further careful scrutiny.
Since NO and H2S appear to act as bacterial defences
against antibiotics, future therapeutic strategies might
involve targeting the gas-generating enzymes – bacterial
NO synthase [58,59,106] and the three H2S-synthesising
enzymes identified thus far [99]. In the case of CO, a more
productive strategy may be to develop clinically effective
and permissible CO-releasing molecules. The most
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Streptococcus pneumoniae, which
commonly used, CORM-2 and CORM-3, are both
ruthenium metal carbonyls and there is likely to be
resistance to using a “non-biological” delivery molecule;
on the other hand, witness the widespread use of cis-
diamminedichloroplatinum(II) (Cisplatin), a chemother-
apy drug that is given to treat testicular, bladder, and other
cancers.
Despite an accelerating interest from microbiologists in
these three remarkable gases, we urgently need more
fundamental research into their synthesis, functions, and
potential roles in therapy against pathogenic microbes.
Abbreviations
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